- Home
- CYCN vs GIXI Comparison
CYCN vs GIXI Comparison
Compare CYCN & GIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.36
N/A
Current Price
$5.45
Company Overview
Basic Information| Metric | CYCN | GIXI |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6M | 14.6M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | CYCN | GIXI |
|---|---|---|
| Price | $3.36 | $5.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 90.6K | 45.4K |
| Earning Date | 05-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.26 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,074,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.70 | N/A |
| 52 Week Low | $1.03 | $5.06 |
| 52 Week High | $8.48 | $6.25 |
Technical Indicators
Market Signals| Indicator | CYCN | GIXI |
|---|---|---|
| Relative Strength Index (RSI) | 41.06 | N/A |
| Support Level | $3.04 | N/A |
| Resistance Level | $3.42 | N/A |
| Average True Range (ATR) | 0.49 | 0.00 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 23.67 | 0.00 |
Price Performance
Historical Comparison CYCN
GIXI
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.